Division of Urology News

Two CHOP Urology operating room nurses discuss how they collaborate with surgeons to care for children from all over the world, demonstrating why a core team that includes both experienced surgeons and staff is key to minimally invasive surgery in children.

CHOP has a leading robot-assisted and laparoscopic surgery practice and one of the most experienced pediatric urology minimally invasive surgery (MIS) programs in the world. Surgeons at CHOP have led advances in minimally invasive robotic surgery and continue to improve patient care, develop new treatment options, and improve outcomes to benefit children across the country and around the world.

Over the past decade, Children’s Hospital of Philadelphia (CHOP) Attending Pediatric Urologist Thomas Kolon, MD, has pioneered the use of nephron-sparing surgery — also known as partial nephrectomy — for Wilms tumor, the most common malignant renal tumor in childhood.

Here, Arun K. Srinivasan, MD, MRCS, shares how his upbringing in India influenced his career path, and he discusses how racial disparities in medicine can be addressed.

CBS Philadelphia Features Dr. Gregory Tasian on rising temperatures and climate change may lead to increased risk of kidney stones.

Douglas Arthur Canning, 65, of Philadelphia, a beloved pediatric urologist and Chief of the Division of Urology at Children’s Hospital of Philadelphia (CHOP), died Monday, May 30, 2022, after suffering severe injuries from a bicycle accident. He passed surrounded by his loving family.

It is with the deepest sadness that we share the news of the sudden passing of Douglas A. Canning, MD, on Memorial Day, Monday, May 30, surrounded by his loving family, after sustaining severe injuries in a cycling accident.

Over the last year, members of our Division of Urology have been busy advancing pediatric urology through research activities ranging from basic science discoveries to innovative 3D modeling of kidney cancers prior to surgery.

Over the past year we have implemented several new protocols to help better understand and address our division’s readmission rates, reoperation rates, and time to the operating room for testicular torsions.

A recent analysis of our multimodal pain management protocol found that emphasizing a transition in perioperative pain management toward non-opioid multimodal regimens utilizing NSAIDs for common urological reconstructive procedures is not only feasible and safe but also may confer an advantage over the use of opiates.